Chunwen Duan

Changsha, 410015, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Generation of a human iPSC line (CSUASOi016-A) modeling X-linked retinoschisis by introducing the RS1 c.214G>A mutation using CRISPR/Cas9.

Generation of a human iPSC line (CSUASOi016-A) modeling X-linked retinoschisis by introducing the RS1 c.214G>A mutation using CRISPR/Cas9.

Journal: Stem cell research

Published: May 10, 2026

Generation of iPSC line CSUASOi015-A from peripheral blood mononuclear cells of an autosomal dominant retinitis pigmentosa patient with a heterozygous deletion of exons 2-8 in PRPF31.

Generation of iPSC line CSUASOi015-A from peripheral blood mononuclear cells of an autosomal dominant retinitis pigmentosa patient with a heterozygous deletion of exons 2-8 in PRPF31.

Journal: Stem cell research

Published: April 08, 2026

Establishment of CSUASOi014-A, an induced pluripotent stem cell line from blood-derived cells of a Chinese patient carrying PRPF31 gene mutation.

Establishment of CSUASOi014-A, an induced pluripotent stem cell line from blood-derived cells of a Chinese patient carrying PRPF31 gene mutation.

Journal: Stem cell research

Published: January 26, 2026

Establishment of non-integrate induced pluripotent stem cell line CSUASOi013-A, from peripheral blood-derived cells of a PRPF31-related dominant retinitis pigmentosa patient.

Establishment of non-integrate induced pluripotent stem cell line CSUASOi013-A, from peripheral blood-derived cells of a PRPF31-related dominant retinitis pigmentosa patient.

Journal: Stem cell research

Published: January 15, 2026

PRPF8 Mutation-Induced Defects in Human iPSC-Derived RPE Are Rescued by Adenine Base Editing.

PRPF8 Mutation-Induced Defects in Human iPSC-Derived RPE Are Rescued by Adenine Base Editing.

Journal: Investigative ophthalmology & visual science

Published: January 14, 2026

Efficient Fabrication of Human Corneal Stromal Cell Spheroids and Promoting Cell Stemness Based on 3D-Printed Derived PDMS Microwell Platform.

Efficient Fabrication of Human Corneal Stromal Cell Spheroids and Promoting Cell Stemness Based on 3D-Printed Derived PDMS Microwell Platform.

Journal: Biomolecules

Published: February 11, 2025

Generation of a gene-corrected isogenic human iPS cell line (CSUASOi006-A-2) from a retinitis pigmentosa patient using CRISPR/Cas9 technology.

Generation of a gene-corrected isogenic human iPS cell line (CSUASOi006-A-2) from a retinitis pigmentosa patient using CRISPR/Cas9 technology.

Journal: Stem cell research

Published: January 12, 2025

Generation of a human iPSC line with heterozygous PRPF8 c.5792C > T, p. T1931M mutation to model retinitis pigmentosa using CRISPR/Cas9 technology.

Generation of a human iPSC line with heterozygous PRPF8 c.5792C > T, p. T1931M mutation to model retinitis pigmentosa using CRISPR/Cas9 technology.

Journal: Stem cell research

Published: January 03, 2025

CRISPR/Cas9-mediated generation of a human induced pluripotent stem cell line with PRPF6 c.2699 G > A mutation to model retinitis pigmentosa.

CRISPR/Cas9-mediated generation of a human induced pluripotent stem cell line with PRPF6 c.2699 G > A mutation to model retinitis pigmentosa.

Journal: Stem cell research

Published: May 30, 2024

Retinal organoids with X-linked retinoschisis RS1 (E72K) mutation exhibit a photoreceptor developmental delay and are rescued by gene augmentation therapy.

Retinal organoids with X-linked retinoschisis RS1 (E72K) mutation exhibit a photoreceptor developmental delay and are rescued by gene augmentation therapy.

Journal: Stem cell research & therapy

Published: February 12, 2024

Generation of a gene-corrected isogenic human iPSC line (CSUASOi006-A-1) from a retinitis pigmentosa patient with heterozygous c.5792C > T mutation in the PRPF8 gene.

Generation of a gene-corrected isogenic human iPSC line (CSUASOi006-A-1) from a retinitis pigmentosa patient with heterozygous c.5792C > T mutation in the PRPF8 gene.

Journal: Stem cell research

Published: January 07, 2024

Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC.

Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC.

Journal: Stem cell research

Published: December 16, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026